These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


371 related items for PubMed ID: 16123425

  • 1. Role of interferon-gamma in a mouse model of allergic conjunctivitis.
    Stern ME, Siemasko K, Gao J, Duong A, Beauregard C, Calder V, Niederkorn JY.
    Invest Ophthalmol Vis Sci; 2005 Sep; 46(9):3239-46. PubMed ID: 16123425
    [Abstract] [Full Text] [Related]

  • 2. Endogenous IL-17 does not play a significant role in the development of experimental murine allergic conjunctivitis.
    Fukushima A, Sumi T, Ishida W, Yamada J, Iwakura Y, Ueno H.
    Int Arch Allergy Immunol; 2008 Sep; 147(3):206-12. PubMed ID: 18594150
    [Abstract] [Full Text] [Related]

  • 3. Differential modulation of allergic eye disease by chronic and acute ascaris infection.
    Schopf L, Luccioli S, Bundoc V, Justice P, Chan CC, Wetzel BJ, Norris HH, Urban JF, Keane-Myers A.
    Invest Ophthalmol Vis Sci; 2005 Aug; 46(8):2772-80. PubMed ID: 16043850
    [Abstract] [Full Text] [Related]

  • 4. Development of an animal model for allergic conjunctivitis: influence of genetic factors and allergen concentration on immune response.
    Giavina-Bianchi P, Kalil J, Rizzo LV.
    Acta Ophthalmol; 2008 Sep; 86(6):670-5. PubMed ID: 18752518
    [Abstract] [Full Text] [Related]

  • 5. Roles of OX40 in the development of murine experimental allergic conjunctivitis: exacerbation and attenuation by stimulation and blocking of OX40.
    Fukushima A, Yamaguchi T, Ishida W, Fukata K, Yagita H, Ueno H.
    Invest Ophthalmol Vis Sci; 2006 Feb; 47(2):657-63. PubMed ID: 16431965
    [Abstract] [Full Text] [Related]

  • 6. Participation of CD11b and F4/80 molecules in the conjunctival eosinophilia of experimental allergic conjunctivitis.
    Fukushima A, Ishida W, Ojima A, Kajisako M, Sumi T, Yamada J, Tsuru E, Miyazaki J, Tominaga A, Yagita H.
    Int Arch Allergy Immunol; 2010 Feb; 151(2):129-36. PubMed ID: 19752566
    [Abstract] [Full Text] [Related]

  • 7. Analysis of the interaction between IFN-gamma and IFN-gammaR in the effector phase of experimental murine allergic conjunctivitis.
    Fukushima A, Sumi T, Fukuda K, Kumagai N, Nishida T, Tsuru E, Ueno H.
    Immunol Lett; 2006 Nov 15; 107(2):119-24. PubMed ID: 16987553
    [Abstract] [Full Text] [Related]

  • 8. 4-1 BB stimulation inhibits allergen-specific immunoglobulin E production and airway hyper-reactivity but partially suppresses bronchial eosinophilic inflammation in a mouse asthma model.
    Cho YS, Kwon B, Lee TH, Kim TB, Moon KA, La S, Lee J, Lee SD, Oh YM, Moon HB.
    Clin Exp Allergy; 2006 Mar 15; 36(3):377-85. PubMed ID: 16499650
    [Abstract] [Full Text] [Related]

  • 9. Engineered recombinant ovomucoid third domain can modulate allergenic response in Balb/c mice model.
    Rupa P, Mine Y.
    Biochem Biophys Res Commun; 2006 Apr 14; 342(3):710-7. PubMed ID: 16494843
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Identification of local Th2 and Th0 lymphocytes in vernal conjunctivitis by cytokine flow cytometry.
    Leonardi A, DeFranchis G, Zancanaro F, Crivellari G, De Paoli M, Plebani M, Secchi AG.
    Invest Ophthalmol Vis Sci; 1999 Nov 14; 40(12):3036-40. PubMed ID: 10549670
    [Abstract] [Full Text] [Related]

  • 13. Modulation of murine experimental allergic conjunctivitis by treatment with alpha-galactosylceramide.
    Fukushima A, Sumi T, Fukuda K, Yamaguchi T, Kumagai N, Nishida T, Ueno H.
    Immunol Lett; 2006 Sep 15; 107(1):32-40. PubMed ID: 16930723
    [Abstract] [Full Text] [Related]

  • 14. TLR2 agonist ameliorates murine experimental allergic conjunctivitis by inducing CD4 positive T-cell apoptosis rather than by affecting the Th1/Th2 balance.
    Fukushima A, Yamaguchi T, Ishida W, Fukata K, Ueno H.
    Biochem Biophys Res Commun; 2006 Jan 27; 339(4):1048-55. PubMed ID: 16337148
    [Abstract] [Full Text] [Related]

  • 15. Roles of galectin-9 in the development of experimental allergic conjunctivitis in mice.
    Fukushima A, Sumi T, Fukuda K, Kumagai N, Nishida T, Okumura K, Akiba H, Yagita H, Ueno H.
    Int Arch Allergy Immunol; 2008 Jan 27; 146(1):36-43. PubMed ID: 18087160
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Inducing ocular allergy with beta-lactoglobulin: a new experimental model.
    Sari A, Dinc E, Yilmaz BC, Adiguzel U, Oztuna S, Tasdelen B.
    Ophthalmic Res; 2010 Jan 27; 44(2):119-24. PubMed ID: 20523103
    [Abstract] [Full Text] [Related]

  • 19. Systemic overexpression of IFN-gamma and IL-5 exacerbates early phase reaction and conjunctival eosinophilia, respectively, in experimental allergic conjunctivitis.
    Ishida W, Tsuru E, Tominaga A, Miyazaki JI, Higuchi T, Sakamoto S, Fukushima A.
    Br J Ophthalmol; 2009 Dec 27; 93(12):1680-5. PubMed ID: 19692377
    [Abstract] [Full Text] [Related]

  • 20. Upregulation of interferon-gamma and interleukin-4, Th cell-derived cytokines by So-Shi-Ho-Tang (Sho-Saiko-To) occurs at the level of antigen presenting cells, but not CD4 T cells.
    Kang H, Choi TW, Ahn KS, Lee JY, Ham IH, Choi HY, Shim ES, Sohn NW.
    J Ethnopharmacol; 2009 May 04; 123(1):6-14. PubMed ID: 19429332
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 19.